NIH Common Fund Researchers Uncover Structure of Important Target for Drug Design
Tuesday, February 21, 2012
Researchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor.
Leading Proteomics Company Transitions to Emerald Bio, Chooses Key Leadership to Address Growing Market Opportunities
Tuesday, February 14, 2012
Emerald BioSystems will now be known as Emerald Bio. The new management changes include the appointment of CEO, George Abe, and the promotion of Dr. Peter Nollert to Chief Technologist.
Proteros Appoints Dr Klaus Hinterding
Monday, February 13, 2012
Dr Klaus Hinterding, formerly at Hoffmann-La Roche Ltd, joins Proteros biostructures GmbH as Chief Scientific Officer and member of the management board.
Structure of Complex Zeolite explains its Role in Naphtha-to-Diesel Conversion
Monday, February 13, 2012
Using electron crystallography scientists have determined that a new zeolite has a unique structure containing discrete pores of different dimensions that are connected together.
Protein Dynamics at Eph Receptor-Ligand Interfaces as Revealed by Crystallography, NMR and MD Simulations
Monday, February 13, 2012
The research highlights the key role of protein dynamics in Eph-ephrin signalling, demonstrating how this would benefit future design of agonists/antagonists targeting Eph receptors.
X-ray Diffraction of Protein Crystal Grown in a Nano-liter Scale Droplet in a Microchannel and Evaluation of Its Applicability
Monday, February 13, 2012
Researchers from Kyushu University describe the technical aspects of the in-situ X-ray diffraction of a protein crystal prepared by a nanodroplet-based crystallization method.
Nancy Hutson Appointed to BioCryst’s Board of Directors
Monday, January 30, 2012
Dr Hutson brings over 30 years of experience as a seasoned professional and leader within the pharmaceutical industry.
Crystal Structure of Urea Carboxylase Provides Insights into the Carboxyltransfer Reaction
Monday, January 30, 2012
Research from the Chinese Academy of Sciences could shed light on the mechanism of these enzymes' catalysis.
Vitamins could lead to the Design of Novel Drugs to Combat Malaria
Friday, January 27, 2012
The research will enable scientists to learn more about the nature of the enzymes required for vitamin biosynthesis by the malaria causing pathogen Plasmodium.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 571 |
|
|
